Watson Pharmaceuticals (WPI)
Q2 2012 Earnings Call
July 26, 2012 8:30 am ET
ExecutivesLisa M. Defrancesco - Former Vice President of Global Investor RelationsPaul M. Bisaro - Chief Executive Officer, President and DirectorR. Todd Joyce - Chief Financial Officer -GlobalGeorge Frederick Wilkinson - President of Global Brands and BiosimilarsSigurdur Oli Olafsson - President of Global GenericsAnalystsGregory B. Gilbert - BofA Merrill Lynch, Research DivisionDavid Amsellem - Piper Jaffray Companies, Research DivisionMarc Goodman - UBS Investment Bank, Research DivisionDavid G. Buck - The Buckingham Research Group IncorporatedTimothy Chiang - CRT Capital Group LLC, Research DivisionChristopher Schott - JP Morgan Chase & Co, Research DivisionJami Rubin - Goldman Sachs Group Inc., Research DivisionAaron Gal - Sanford C. Bernstein & Co., LLC., Research DivisionElliot Wilbur - Needham & Company, LLC, Research DivisionMichael Faerm - Crédit Suisse AG, Research DivisionKen Cacciatore - Cowen and Company, LLC, Research DivisionGary Nachman - Susquehanna Financial Group, LLLP, Research DivisionMichael Kallai Tong - Wells Fargo Securities, LLC, Research DivisionDavid Risinger - Morgan Stanley, Research DivisionRandall Stanicky - Canaccord Genuity, Research DivisionDouglas D. Tsao - Barclays Capital, Research DivisionShibani Malhotra - RBC Capital Markets, LLC, Research DivisionPresentationOperator
Previous Statements by WPI
» Watson Pharmaceuticals' CEO Hosts 2012 Annual Shareholders' Meeting (Transcript)
» Watson Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Watson Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV